Herpes Virus Infections in Kidney Transplant Patients

Conditions: Kidney Transplant; Complications, Varicella Zoster Virus Infection, Vaccine-Preventable Diseases

Summary

Kidney transplant recipients are at increased risk of infections, including Varicella-zoster virus (VZV) infections. Vaccination against VZV is routinely offered to all kidney transplant recipients and candidates in Denmark. In this exploratory observational study, the VZV specific immune response in kidney transplant candidates and recipients will be characterized at different time points in relation to transplantation, vaccination and infections. More knowledge on the immune reaction to transplantation, VZV vaccination and VZV infections may provide improved strategies for prevention and treatment of VZV infections in kidney transplant candidates and recipients.

Eligibility Criteria

Inclusion Criteria:Kidney transplant recipient transplanted after 2019-01-01 OR on the kidney transplant waitlistHas been offered Shingrix® vaccinationExclusion Criteria:Lack of informed consentInability to understand the study information

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05604911). StuddyBuddy aggregates publicly available trial information.